{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:09:41Z","timestamp":1793722181780,"version":"4.6.1"},"reference-count":218,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG069781"],"award-info":[{"award-number":["AG069781"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK091538"],"award-info":[{"award-number":["DK091538"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["IRG-21-049-61-IRG131"],"award-info":[{"award-number":["IRG-21-049-61-IRG131"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bbalip.2022.159209","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T04:45:06Z","timestamp":1659588306000},"page":"159209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis"],"prefix":"10.1016","volume":"1867","author":[{"given":"Curtis C.","family":"Hughey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Puchalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2022.159209_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0015","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0020","first-page":"167","article-title":"Pathogenesis and prevention of hepatic steatosis","volume":"11","author":"Nassir","year":"2015","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"key":"10.1016\/j.bbalip.2022.159209_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jceh.2019.09.005","article-title":"Natural history of simple steatosis or nonalcoholic fatty liver","volume":"10","author":"De","year":"2020","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0030","first-page":"445","article-title":"Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal, expert rev","volume":"3","author":"Alkhouri","year":"2009","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0040","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2022.159209_bb0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0050","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-med-051215-031109","article-title":"Nonalcoholic steatohepatitis","volume":"68","author":"Suzuki","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0060","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0065","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12072-015-9679-0","article-title":"Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis","volume":"10","author":"Mohamad","year":"2016","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbalip.2022.159209_bb0070","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/lt.25657","article-title":"Nonalcoholic steatohepatitis after liver transplantation","volume":"26","author":"Cotter","year":"2020","journal-title":"Liver Transpl."},{"key":"10.1016\/j.bbalip.2022.159209_bb0080","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cld.708","article-title":"An update on the pharmacological treatment of nonalcoholic fatty liver disease: beyond lifestyle modifications","volume":"11","author":"Alkhouri","year":"2018","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"10.1016\/j.bbalip.2022.159209_bb0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3945\/an.113.004648","article-title":"Hepatic fatty acid trafficking: multiple forks in the road","volume":"4","author":"Mashek","year":"2013","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.bbalip.2022.159209_bb0095","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159209_bb0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbalip.2022.159209_bb0110","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.bbalip.2022.159209_bb0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","article-title":"Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis","volume":"155","author":"Musso","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0120","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1091980","article-title":"Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease","volume":"28","author":"Malhi","year":"2008","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbalip.2022.159209_bb0125","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1194\/jlr.R066357","article-title":"Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis","volume":"57","author":"Hirsova","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159209_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","article-title":"Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease","volume":"1061","author":"Farrell","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0135","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ni.3772","article-title":"Limiting inflammation-the negative regulation of NF-kappaB and the NLRP3 inflammasome","volume":"18","author":"Afonina","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0140","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.dsx.2020.09.026","article-title":"Pathophysiological mechanisms underlying MAFLD","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.bbalip.2022.159209_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159209_bb0150","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2022.159209_bb0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tem.2015.05.006","article-title":"The extracellular matrix and insulin resistance","volume":"26","author":"Williams","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bbalip.2022.159209_bb0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.nutr.21.1.193","article-title":"Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system","volume":"21","author":"Reddy","year":"2001","journal-title":"Annu. Rev. Nutr."},{"issue":"Pt 2","key":"10.1016\/j.bbalip.2022.159209_bb0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj3200345","article-title":"Mammalian mitochondrial beta-oxidation","volume":"320","author":"Eaton","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2022.159209_bb0170","doi-asserted-by":"crossref","first-page":"E413","DOI":"10.1152\/ajpendo.00105.2017","article-title":"Inter-relations between 3-hydroxypropionate and propionate metabolism in rat liver: relevance to disorders of propionyl-CoA metabolism","volume":"313","author":"Wilson","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.bi.49.070180.002143","article-title":"Regulation of hepatic fatty acid oxidation and ketone body production","volume":"49","author":"McGarry","year":"1980","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","author":"Moore","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0885-4505(86)90080-0","article-title":"14CO2 production is no adequate measure of [14C]fatty acid oxidation","volume":"35","author":"Veerkamp","year":"1986","journal-title":"Biochem Med Metab Biol"},{"key":"10.1016\/j.bbalip.2022.159209_bb0190","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1194\/jlr.M023382","article-title":"Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver","volume":"53","author":"Satapati","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159209_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024084","article-title":"Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet","volume":"6","author":"Serviddio","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2022.159209_bb0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/kfx253","article-title":"Asking the right questions with animal models: methionine- and choline-deficient model in predicting adverse drug reactions in human NASH","volume":"161","author":"Li","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbalip.2022.159209_bb0205","first-page":"2980","article-title":"Fatty acid oxidation, substrate shuttles, and activity of the citric acid cycle in hepatocellular carcinomas of varying differentiation","volume":"36","author":"Cederbaum","year":"1976","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2022.159209_bb0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1432-1033.1992.tb17288.x","article-title":"Evidence for an impaired long-chain fatty acid oxidation and ketogenesis in fao hepatoma cells","volume":"209","author":"Prip-Buus","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1194\/jlr.RA119000177","article-title":"Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation","volume":"61","author":"Lundsgaard","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159209_bb0220","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.celrep.2017.06.080","article-title":"Loss of hepatic mitochondrial long-chain fatty acid oxidation confers resistance to diet-induced obesity and glucose intolerance","volume":"20","author":"Lee","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2022.159209_bb0225","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0230","article-title":"Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver","volume":"5","author":"Fletcher","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbalip.2022.159209_bb0235","doi-asserted-by":"crossref","first-page":"E484","DOI":"10.1152\/ajpendo.00492.2015","article-title":"Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity","volume":"310","author":"Patterson","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/JOE-19-0007","article-title":"Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis","volume":"241","author":"Kalavalapalli","year":"2019","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng0596-18","article-title":"Leptin receptor missense mutation in the fatty zucker rat","volume":"13","author":"Phillips","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2022.159209_bb0250","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/db08-0226","article-title":"Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism","volume":"57","author":"Satapati","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2022.159209_bb0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2016.06.005","article-title":"Assessment of hepatic mitochondrial oxidation and pyruvate cycling in NAFLD by (13)C magnetic resonance spectroscopy","volume":"24","author":"Petersen","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0260","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"Satapati","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159209_bb0265","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1074\/jbc.M116.720631","article-title":"Propionate increases hepatic pyruvate cycling and anaplerosis and alters mitochondrial metabolism","volume":"291","author":"Perry","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nm.3415","article-title":"Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy","volume":"20","author":"Befroy","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nm.3789","article-title":"Limitations of detection of anaplerosis and pyruvate cycling from metabolism of [1-13C] acetate","volume":"21","author":"Burgess","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0280","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nm.3790","article-title":"Response to burgess","volume":"21","author":"Befroy","year":"2015","journal-title":"Nat. Med."},{"issue":"49","key":"10.1016\/j.bbalip.2022.159209_bb0285","doi-asserted-by":"crossref","first-page":"20125","DOI":"10.1074\/jbc.M117.811547","article-title":"Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice","volume":"292","author":"Hughey","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0290","article-title":"Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome","volume":"3","author":"d'Avignon","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbalip.2022.159209_bb0295","doi-asserted-by":"crossref","first-page":"E727","DOI":"10.1152\/ajpendo.00216.2015","article-title":"Tracer-based assessments of hepatic anaplerotic and TCA cycle flux: practicality, stoichiometry, and hidden assumptions","volume":"309","author":"Previs","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107986","article-title":"In vivo estimates of liver metabolic flux assessed by (13)C-propionate and (13)C-lactate are impacted by tracer recycling and equilibrium assumptions","volume":"32","author":"Hasenour","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2022.159209_bb0305","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI107593","article-title":"Splanchnic glucose and amino acid metabolism in obesity","volume":"53","author":"Felig","year":"1974","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159209_bb0310","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.1038\/ncomms9994","article-title":"Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease","volume":"7","author":"Hyotylainen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2022.159209_bb0315","doi-asserted-by":"crossref","first-page":"E584","DOI":"10.1152\/ajpendo.00272.2010","article-title":"Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation?","volume":"299","author":"Hodson","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"856","key":"10.1016\/j.bbalip.2022.159209_bb0320","first-page":"e841","article-title":"Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals","volume":"846\u2013856","author":"Iozzo","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0325","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1016\/S0021-9258(19)42075-9","article-title":"Pyruvate carboxylase. Studies of activator-independent catalysis and of the specificity of activation by acyl derivatives of coenzyme A for the enzyme from rat liver","volume":"249","author":"Scrutton","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0330","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/liv.14309","article-title":"Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: a palmitate breath test study","volume":"40","author":"Naguib","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2022.159209_bb0335","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1572-0241.2003.07725.x","article-title":"Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test","volume":"98","author":"Miele","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0340","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4093\/dmj.2016.40.5.376","article-title":"Statins increase mitochondrial and peroxisomal fatty acid oxidation in the liver and prevent non-alcoholic steatohepatitis in mice","volume":"40","author":"Park","year":"2016","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.bbalip.2022.159209_bb0345","doi-asserted-by":"crossref","first-page":"11944","DOI":"10.1074\/jbc.RA118.002568","article-title":"Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates","volume":"293","author":"Hughey","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2019.02.006","article-title":"Dysregulated transmethylation leading to hepatocellular carcinoma compromises redox homeostasis and glucose formation","volume":"23","author":"Hughey","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.bbalip.2022.159209_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101452","article-title":"Disrupted liver oxidative metabolism in glycine N-methyltransferase-deficient mice is mitigated by dietary methionine restriction","volume":"58","author":"Rome","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.bbalip.2022.159209_bb0360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2014.02.023","article-title":"Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity","volume":"356","author":"Desideri","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbalip.2022.159209_bb0365","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.molmed.2011.06.001","article-title":"Revisiting the TCA cycle: signaling to tumor formation","volume":"17","author":"Raimundo","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0370","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biochi.2017.02.008","article-title":"Genetic alterations in Krebs cycle and its impact on cancer pathogenesis","volume":"135","author":"Sajnani","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.bbalip.2022.159209_bb0375","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1152\/ajpendo.00098.2019","article-title":"Sex modulates hepatic mitochondrial adaptations to high-fat diet and physical activity","volume":"317","author":"McCoin","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0380","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1074\/jbc.M114.615716","article-title":"Integrin alpha1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance","volume":"290","author":"Williams","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0385","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bj2310439","article-title":"Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob\/ob) mice","volume":"231","author":"Brady","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2022.159209_bb0390","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00407.2007","article-title":"Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet","volume":"294","author":"Romestaing","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0395","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061407","article-title":"Exercise attenuates the transition from fatty liver to steatohepatitis and reduces tumor formation in mice","volume":"12","author":"Guarino","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbalip.2022.159209_bb0405","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1113\/JP274281","article-title":"Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis","volume":"595","author":"Morris","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0410","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.biocel.2014.07.011","article-title":"Exercise alters liver mitochondria phospholipidomic profile and mitochondrial activity in non-alcoholic steatohepatitis","volume":"54","author":"Goncalves","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0415","first-page":"441","article-title":"Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats","volume":"2011","author":"Ciapaite","year":"1811","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2022.159209_bb0420","doi-asserted-by":"crossref","first-page":"G666","DOI":"10.1152\/ajpgi.00213.2016","article-title":"A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition","volume":"312","author":"Krishnan","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0425","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/nm.3735","article-title":"Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity","volume":"20","author":"Arruda","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0430","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s42255-020-0209-6","article-title":"Resolution of NASH and hepatic fibrosis by the GLP-1R\/GcgR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis","volume":"2","author":"Boland","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.bbalip.2022.159209_bb0435","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3748\/wjg.v24.i16.1748","article-title":"Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction","volume":"24","author":"Boland","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031101","article-title":"Adaptation of mitochondrial substrate flux in a mouse model of nonalcoholic fatty liver disease","volume":"21","author":"Stankova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2022.159209_bb0445","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.febslet.2006.02.078","article-title":"Decreased ANT content in zucker fatty rats: relevance for altered hepatic mitochondrial bioenergetics in steatosis","volume":"580","author":"Teodoro","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2022.159209_bb0450","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"Perez-Carreras","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0455","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0460","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.282.17.1659","article-title":"Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study","volume":"282","author":"Cortez-Pinto","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2022.159209_bb0465","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2337\/dc21-1758","article-title":"Impaired hepatic mitochondrial capacity in nonalcoholic steatohepatitis associated with type 2 diabetes","volume":"45","author":"Gancheva","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbalip.2022.159209_bb0470","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/s41467-022-30629-5","article-title":"Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration","volume":"13","author":"Pedersen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2022.159209_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2022.159209_bb0480","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1046\/j.1432-1033.2002.03204.x","article-title":"Inactivation of the 2-oxo acid dehydrogenase complexes upon generation of intrinsic radical species","volume":"269","author":"Bunik","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0485","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1523\/JNEUROSCI.1899-04.2004","article-title":"Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species","volume":"24","author":"Starkov","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2022.159209_bb0490","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.1523\/JNEUROSCI.1842-04.2004","article-title":"Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase","volume":"24","author":"Tretter","year":"2004","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bbalip.2022.159209_bb0495","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cmet.2019.03.014","article-title":"Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver","volume":"29","author":"Cappel","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0500","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/hep.25632","article-title":"Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha","volume":"56","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0505","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/ncomms3508","article-title":"Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma","volume":"4","author":"Ma","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2022.159209_bb0510","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2016.08.025","article-title":"The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells","volume":"382","author":"Shi","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbalip.2022.159209_bb0515","doi-asserted-by":"crossref","first-page":"14420","DOI":"10.1038\/ncomms14420","article-title":"Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation","volume":"8","author":"Bian","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2022.159209_bb0520","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fonc.2018.00611","article-title":"PCK1 downregulation promotes TXNRD1 expression and hepatoma cell growth via the Nrf2\/Keap1 pathway","volume":"8","author":"Tuo","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0525","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000489811","article-title":"Overexpression of PCK1 gene antagonizes hepatocellular carcinoma through the activation of gluconeogenesis and suppression of glycolysis pathways","volume":"47","author":"Tang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0530","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41388-017-0070-6","article-title":"Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbalip.2022.159209_bb0535","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1073\/pnas.0510977103","article-title":"The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria","volume":"103","author":"Kussmaul","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2022.159209_bb0540","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1016\/j.febslet.2006.10.008","article-title":"The single subunit NADH dehydrogenase reduces generation of reactive oxygen species from complex I","volume":"580","author":"Seo","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2022.159209_bb0545","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-020-2337-2","article-title":"Hepatic NADH reductive stress underlies common variation in metabolic traits","volume":"583","author":"Goodman","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2022.159209_bb0550","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tem.2011.12.008","article-title":"Linking mitochondrial bioenergetics to insulin resistance via redox biology","volume":"23","author":"Fisher-Wellman","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bbalip.2022.159209_bb0555","article-title":"Mitochondrial oxidative function in NAFLD: friend or foe?","volume":"50","author":"Shum","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0560","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/liv.12707","article-title":"The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis","volume":"35","author":"Fares","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2022.159209_bb0565","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3109\/00365521.2015.1030687","article-title":"The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus","volume":"50","author":"Liu","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0570","doi-asserted-by":"crossref","first-page":"9307064","DOI":"10.1155\/2016\/9307064","article-title":"In situ evaluation of oxidative stress in rat fatty liver induced by a methionine- and choline-deficient diet","volume":"2016","author":"Freitas","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbalip.2022.159209_bb0575","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/ars.2010.3395","article-title":"Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice","volume":"15","author":"Eccleston","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbalip.2022.159209_bb0580","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12988","article-title":"Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL\/6J mice","volume":"4","author":"Lohr","year":"2016","journal-title":"Physiological reports"},{"key":"10.1016\/j.bbalip.2022.159209_bb0585","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/carcin\/21.5.983","article-title":"Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria","volume":"21","author":"Hensley","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbalip.2022.159209_bb0590","doi-asserted-by":"crossref","first-page":"G1070","DOI":"10.1152\/ajpgi.00228.2004","article-title":"Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease","volume":"287","author":"Gao","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165621","article-title":"Protective effect of metformin against palmitate-induced hepatic cell death","volume":"1866","author":"Geng","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbalip.2022.159209_bb0600","doi-asserted-by":"crossref","first-page":"33425","DOI":"10.1074\/jbc.M109.049478","article-title":"Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis","volume":"284","author":"Noguchi","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0605","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.metabol.2013.10.009","article-title":"Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes","volume":"63","author":"Egnatchik","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2022.159209_bb0610","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.molmet.2014.05.004","article-title":"ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload","volume":"3","author":"Egnatchik","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.bbalip.2022.159209_bb0615","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41420-022-00840-w","article-title":"Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model","volume":"8","author":"Xu","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bbalip.2022.159209_bb0620","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.biomaterials.2016.03.003","article-title":"CdSe\/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation","volume":"90","author":"Lu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbalip.2022.159209_bb0625","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1089\/ars.2014.5868","article-title":"Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation","volume":"22","author":"Zhang","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbalip.2022.159209_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104967","article-title":"Activation of NLRP3 inflammasome in hepatocytes after exposure to cobalt nanoparticles: the role of oxidative stress","volume":"69","author":"Feng","year":"2020","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bbalip.2022.159209_bb0635","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.febslet.2013.11.033","article-title":"TNF-alpha mediates mitochondrial uncoupling and enhances ROS-dependent cell migration via NF-kappaB activation in liver cells","volume":"588","author":"Kastl","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2022.159209_bb0640","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1194\/jlr.R066597","article-title":"Oxidative stress and lipotoxicity","volume":"57","author":"Hauck","year":"2016","journal-title":"J. Lipid Res."},{"issue":"Suppl 1","key":"10.1016\/j.bbalip.2022.159209_bb0645","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1440-1746.2010.06592.x","article-title":"Reactive oxygen and mechanisms of inflammatory liver injury: present concepts","volume":"26","author":"Jaeschke","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0650","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0168-8278(02)00073-9","article-title":"In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases","volume":"37","author":"Seki","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0655","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0004-28032011000100015","article-title":"Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis","volume":"48","author":"Marcolin","year":"2011","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0660","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1124\/dmd.106.010645","article-title":"Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4 alpha expression","volume":"34","author":"Sugatani","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbalip.2022.159209_bb0665","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.M083741","article-title":"Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice","volume":"59","author":"Schuster","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159209_bb0670","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","article-title":"NASH: a mitochondrial disease","volume":"42","author":"Pessayre","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9100233","article-title":"Mitochondrial dysfunction in the transition from NASH to HCC","volume":"9","author":"Leveille","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.bbalip.2022.159209_bb0680","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","article-title":"Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation","volume":"67","author":"Ibrahim","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbalip.2022.159209_bb0685","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0690","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159209_bb0695","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","article-title":"Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis","volume":"11","author":"An","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2022.159209_bb0700","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2018.00455","article-title":"Succinate as a regulator of hepatic stellate cells in liver fibrosis","volume":"9","author":"Cho","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bbalip.2022.159209_bb0705","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.3748\/wjg.v23.i15.2685","article-title":"Changes in human hepatic metabolism in steatosis and cirrhosis","volume":"23","author":"Schofield","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0710","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0715","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/liv.14370","article-title":"Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: effects of DHA supplementation","volume":"40","author":"Liu","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2022.159209_bb0720","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bbrc.2015.06.023","article-title":"Succinate causes alpha-SMA production through GPR91 activation in hepatic stellate cells","volume":"463","author":"Li","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2022.159209_bb0725","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nature02488","article-title":"Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors","volume":"429","author":"He","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2022.159209_bb0730","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tcb.2013.11.008","article-title":"Succinate: a metabolic signal in inflammation","volume":"24","author":"Mills","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0735","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jhep.2007.03.016","article-title":"Succinate is a paracrine signal for liver damage","volume":"47","author":"Correa","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0740","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ni.1657","article-title":"Triggering the succinate receptor GPR91 on dendritic cells enhances immunity","volume":"9","author":"Rubic","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0745","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.20160061","article-title":"GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis","volume":"213","author":"Littlewood-Evans","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0750","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbrc.2018.01.106","article-title":"Succinate induces hepatic fibrogenesis by promoting activation, proliferation, and migration, and inhibiting apoptosis of hepatic stellate cells","volume":"496","author":"Park","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2022.159209_bb0755","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1074\/jbc.M115.692244","article-title":"Sirtuin 3 (SIRT3) regulates alpha-smooth muscle actin (alpha-SMA) production through the succinate dehydrogenase-G protein-coupled receptor 91 (GPR91) pathway in hepatic stellate cells","volume":"291","author":"Li","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081808","article-title":"The NLRP3 inflammasome: metabolic regulation and contribution to inflammaging","volume":"9","author":"Meyers","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbalip.2022.159209_bb0765","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1053\/j.gastro.2021.08.030","article-title":"Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity","volume":"161","author":"Azzimato","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0770","doi-asserted-by":"crossref","first-page":"6242697","DOI":"10.1155\/2017\/6242697","article-title":"Serum and liver tissue metabonomic study on fatty liver in rats induced by high-fat diet and intervention effects of traditional chinese medicine qushi huayu decoction","volume":"2017","author":"Gou","year":"2017","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119852","article-title":"Dimethyl fumarate reduces oxidative stress, inflammation and fat deposition by modulation of Nrf2, SREBP-1c and NF-kappaB signaling in HFD fed mice","volume":"283","author":"Vanani","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbalip.2022.159209_bb0780","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/liv.14483","article-title":"Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease","volume":"40","author":"Sangineto","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2022.159209_bb0785","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020314","article-title":"Plasma Krebs cycle intermediates in nonalcoholic fatty liver disease","volume":"9","author":"Sandlers","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0790","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.febslet.2013.06.019","article-title":"Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production","volume":"587","author":"van de Wier","year":"2013","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.bbalip.2022.159209_bb0795","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41418-020-0491-6","article-title":"Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD\/NASH","volume":"27","author":"Tan","year":"2020","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.bbalip.2022.159209_bb0800","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0805","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/bj2040399","article-title":"The role of leucine in ketogenesis in starved rats","volume":"204","author":"Thomas","year":"1982","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2022.159209_bb0810","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0026-0495(72)90059-5","article-title":"Regulation of ketogenesis and clinical aspects of the ketotic state","volume":"21","author":"McGarry","year":"1972","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2022.159209_bb0815","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1152\/ajpendo.00058.2020","article-title":"Beta-hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro","volume":"319","author":"Mey","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0820","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/liv.12769","article-title":"Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans","volume":"35","author":"Mannisto","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2022.159209_bb0825","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1478-3231.2009.02076.x","article-title":"Liver fat and lipid oxidation in humans","volume":"29","author":"Kotronen","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2022.159209_bb0830","doi-asserted-by":"crossref","first-page":"G567","DOI":"10.1152\/ajpgi.00042.2009","article-title":"Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion","volume":"297","author":"Dasarathy","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0835","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MEG.0b013e328345c8c7","article-title":"Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis","volume":"23","author":"Dasarathy","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0840","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0845","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1210\/jc.2019-00875","article-title":"Hepatic fatty acid balance and hepatic fat content in humans with severe obesity","volume":"104","author":"Lytle","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0850","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbalip.2022.159209_bb0855","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2003.50095","article-title":"Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis","volume":"37","author":"Chalasani","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb0860","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2169\/internalmedicine.31.978","article-title":"Resistance to ketosis in moderately obese patients: influence of fatty liver","volume":"31","author":"Inokuchi","year":"1992","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb0865","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1136\/gutjnl-2012-302789","article-title":"Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease","volume":"62","author":"Croci","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.bbalip.2022.159209_bb0870","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11110737","article-title":"Aqueous metabolite trends for the progression of nonalcoholic fatty liver disease in female bariatric surgery patients by targeted (1)H-NMR metabolomics","volume":"11","author":"Robinson","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.bbalip.2022.159209_bb0875","doi-asserted-by":"crossref","first-page":"14832","DOI":"10.1096\/fj.202001495R","article-title":"Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD","volume":"34","author":"Muyyarikkandy","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2022.159209_bb0880","doi-asserted-by":"crossref","first-page":"E1226","DOI":"10.1152\/ajpendo.00033.2010","article-title":"Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet","volume":"298","author":"Sunny","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0885","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103400","article-title":"Association between fasting ketonuria and advanced liver fibrosis in non-alcoholic fatty liver disease patients without prediabetes and diabetes mellitus","volume":"13","author":"Lim","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bbalip.2022.159209_bb0890","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1349-7006.2009.01086.x","article-title":"Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis","volume":"100","author":"Gao","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbalip.2022.159209_bb0895","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biocel.2017.08.016","article-title":"miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma","volume":"91","author":"Su","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0900","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcmgh.2017.05.004","article-title":"Identification of the consistently altered metabolic targets in human hepatocellular carcinoma","volume":"4","author":"Nwosu","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0905","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121876","article-title":"HMGCS2 mediates ketone production and regulates the proliferation and metastasis of hepatocellular carcinoma","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbalip.2022.159209_bb0910","first-page":"2433","article-title":"Regulation of D-beta-hydroxybutyrate dehydrogenase in rat hepatoma cell lines","volume":"49","author":"Zhang","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2022.159209_bb0915","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/cr.2016.109","article-title":"Zhang, hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress","volume":"26","author":"Huang","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.bbalip.2022.159209_bb0920","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1210\/jc.2015-2649","article-title":"Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men","volume":"100","author":"Pramfalk","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0925","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1017\/S0007114510004472","article-title":"Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men","volume":"105","author":"Marinou","year":"2011","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbalip.2022.159209_bb0930","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","article-title":"Physiological roles of ketone bodies as substrates and signals in mammalian tissues","volume":"60","author":"Robinson","year":"1980","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbalip.2022.159209_bb0935","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cellsig.2016.04.005","article-title":"Beta-hydroxybutyrate: a signaling metabolite in starvation response?","volume":"28","author":"Rojas-Morales","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbalip.2022.159209_bb0940","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","article-title":"Ketone bodies as signaling metabolites","volume":"25","author":"Newman","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bbalip.2022.159209_bb0945","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1172\/JCI76388","article-title":"Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia","volume":"124","author":"Cotter","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159209_bb0950","first-page":"2056","article-title":"Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a low-carbohydrate ketogenic diet","volume":"2015","author":"Douris","year":"1852","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2022.159209_bb0955","doi-asserted-by":"crossref","first-page":"G956","DOI":"10.1152\/ajpgi.00539.2010","article-title":"Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet","volume":"300","author":"Garbow","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbalip.2022.159209_bb0960","first-page":"374","article-title":"Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease","volume":"15","author":"Schugar","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbalip.2022.159209_bb0965","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jimd.12243","article-title":"Deficiency of 3-hydroxybutyrate dehydrogenase (BDH1) in mice causes low ketone body levels and fatty liver during fasting","volume":"43","author":"Otsuka","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbalip.2022.159209_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101269","article-title":"Diminished ketone interconversion, hepatic TCA cycle flux, and glucose production in D-beta-hydroxybutyrate dehydrogenase hepatocyte-deficient mice","volume":"53","author":"Stagg","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0975","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2009.09.001","article-title":"GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors","volume":"30","author":"Ahmed","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbalip.2022.159209_bb0980","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa370","article-title":"Ketone body, 3-hydroxybutyrate: minor metabolite - major medical manifestations","volume":"105","author":"Moller","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb0985","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/219083a0","article-title":"Direct regulatory effect of ketones on lipolysis and on glucose concentrations in man","volume":"219","author":"Senior","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2022.159209_bb0990","doi-asserted-by":"crossref","first-page":"26649","DOI":"10.1074\/jbc.C500213200","article-title":"(D)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G","volume":"280","author":"Taggart","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159209_bb0995","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","article-title":"PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect","volume":"9","author":"Tunaru","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb1000","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1210\/jc.2009-2622","article-title":"Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease","volume":"95","author":"Fabbrini","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb1005","doi-asserted-by":"crossref","first-page":"148ra115","DOI":"10.1126\/scitranslmed.3003877","article-title":"Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression","volume":"4","author":"Lauring","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb1010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.metabol.2015.10.001","article-title":"Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2","volume":"65","author":"Graff","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2022.159209_bb1015","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1073\/pnas.1016088108","article-title":"Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)","volume":"108","author":"Kimura","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbalip.2022.159209_bb1020","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1002\/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1","article-title":"PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily","volume":"31","author":"Schaub","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbalip.2022.159209_bb1025","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1096\/fj.12-223933","article-title":"The role of HCA2 (GPR109A) in regulating macrophage function","volume":"27","author":"Zandi-Nejad","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2022.159209_bb1030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/bbrc.2000.3678","article-title":"cDNA representational difference analysis of human neutrophils stimulated by GM-CSF","volume":"277","author":"Yousefi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2022.159209_bb1035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/ATVBAHA.111.241836","article-title":"Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms","volume":"32","author":"Digby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2022.159209_bb1040","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI41651","article-title":"Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells","volume":"121","author":"Lukasova","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159209_bb1045","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/983401","article-title":"BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-kappaB activation","volume":"2014","author":"Fu","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbalip.2022.159209_bb1050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-014-0230-3","article-title":"Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms","volume":"12","author":"Fu","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbalip.2022.159209_bb1055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2022.159209_bb1060","doi-asserted-by":"crossref","first-page":"66444","DOI":"10.18632\/oncotarget.12119","article-title":"Beta-hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation","volume":"7","author":"Bae","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbalip.2022.159209_bb1065","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","article-title":"Beta-hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares","volume":"18","author":"Goldberg","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2022.159209_bb1070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cmet.2018.10.015","article-title":"Hepatocyte-macrophage acetoacetate shuttle protects against tissue fibrosis","volume":"29","author":"Puchalska","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159209_bb1075","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1159\/000358664","article-title":"Beta-hydroxybutyrate activates the NF-kappaB signaling pathway to promote the expression of pro-inflammatory factors in calf hepatocytes","volume":"33","author":"Shi","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbalip.2022.159209_bb1080","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2337\/diabetes.51.7.2287","article-title":"Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency","volume":"51","author":"Jain","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2022.159209_bb1085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000339286","article-title":"Elevated acetoacetate and monocyte chemotactic protein-1 levels in cord blood of infants of diabetic mothers","volume":"102","author":"Kurepa","year":"2012","journal-title":"Neonatology"},{"key":"10.1016\/j.bbalip.2022.159209_bb1090","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/oby.2008.678","article-title":"Effects of insulin on ketogenesis following fasting in lean and obese men","volume":"17","author":"Soeters","year":"2009","journal-title":"Obesity (Silver Spring)"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198122000993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198122000993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:13:54Z","timestamp":1761387234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198122000993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":218,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1388198122000993"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2022.159209","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2022.159209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"159209"}}